Percutaneous coronary intervention in patients with documented coronary vasospasm during long-term follow-up

Ju Hyeon Kim1, Jinoh Park2, Yujin Yang3

  • 1Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

Insights

Coronary artery spasm (CAS) is a risk factor for developing fixed stenosis requiring percutaneous coronary intervention (PCI). Physicians should carefully monitor patients with documented CAS, even with initially insignificant stenosis.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • The link between coronary artery spasm (CAS) and fixed atherosclerotic coronary stenosis (FS) is not fully understood.
  • CAS may precede or contribute to the development of significant coronary artery disease.

Purpose of the Study:

  • To evaluate the incidence of fixed stenosis requiring percutaneous coronary intervention (PCI) in patients with documented CAS.
  • To analyze the clinical features of patients with CAS and subsequent need for PCI.

Main Methods:

  • Analysis of clinical data from 3556 patients with a median follow-up of 9.4 years.
  • Utilized non-invasive ergonovine spasm provocation testing with echocardiography (erg echo) to document CAS.

Main Results:

  • Coronary artery spasm (CAS) was documented in 23.3% of patients, who had more coronary risk factors.
  • Patients with CAS had significantly lower 10-year overall and PCI-free survival rates.
  • Documented CAS independently predicted the need for later PCI, with high concordance between initial spasm and later PCI territories.

Conclusions:

  • Coronary artery spasm (CAS) is a significant risk factor for developing fixed stenosis requiring PCI.
  • Vigilant follow-up is crucial for patients diagnosed with CAS, especially those with initially mild stenosis.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
49
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
43
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
39
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
2.1K